1200 related articles for article (PubMed ID: 19301378)
21. Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation?
Kazmi MA; Mahdi-Rogers M; Sanvito L
Autoimmunity; 2008 Dec; 41(8):611-5. PubMed ID: 18958756
[TBL] [Abstract][Full Text] [Related]
22. Intravenous immunoglobulins in the treatment of immune neuropathies.
Kieseier BC; Meyer Zu Hörste G; Lehmann HC; Gold R; Hartung HP
Curr Opin Neurol; 2008 Oct; 21(5):555-62. PubMed ID: 18769249
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].
Iijima M; Koike H; Sobue G
Nihon Rinsho; 2012 Apr; 70(4):715-21. PubMed ID: 22568158
[TBL] [Abstract][Full Text] [Related]
24. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
Nobile-Orazio E
J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
[TBL] [Abstract][Full Text] [Related]
25. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
[TBL] [Abstract][Full Text] [Related]
26. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
[TBL] [Abstract][Full Text] [Related]
28. Therapy of CIDP and related immune-mediated neuropathies.
Koski CL
Neurology; 2002 Dec; 59(12 Suppl 6):S22-7. PubMed ID: 12499467
[TBL] [Abstract][Full Text] [Related]
29. Chronic immune demyelinating neuropathies.
Lopate G; Pestronk A
Semin Neurol; 1994 Jun; 14(2):131-6. PubMed ID: 7527153
[TBL] [Abstract][Full Text] [Related]
30. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
Dalakas MC
Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Guillain-Barré syndrome and CIDP.
van Doorn PA
J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
[TBL] [Abstract][Full Text] [Related]
32. Differential diagnosis of chronic dysimmune demyelinating polyneuropathies with and without anti-MAG antibodies.
Isoardo G; Migliaretti G; Ciaramitaro P; Rota E; Poglio F; Tavella A; Paolasso I; Cavallo F; Bergamasco B; Cocito D
Muscle Nerve; 2005 Jan; 31(1):52-8. PubMed ID: 15536620
[TBL] [Abstract][Full Text] [Related]
33. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
Uzenot D; Azulay JP; Pouget J
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
[TBL] [Abstract][Full Text] [Related]
34. Chronic Immune-Mediated Polyneuropathies.
Cox SZ; Gwathmey KG
Clin Geriatr Med; 2021 May; 37(2):327-345. PubMed ID: 33858614
[TBL] [Abstract][Full Text] [Related]
35. Update on therapy of chronic immune-mediated neuropathies.
Briani C; Cocito D; Campagnolo M; Doneddu PE; Nobile-Orazio E
Neurol Sci; 2022 Dec; 43(Suppl 2):605-614. PubMed ID: 33452933
[TBL] [Abstract][Full Text] [Related]
36. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy.
Dalakas MC; Rakocevic G; Salajegheh M; Dambrosia JM; Hahn AF; Raju R; McElroy B
Ann Neurol; 2009 Mar; 65(3):286-93. PubMed ID: 19334068
[TBL] [Abstract][Full Text] [Related]
37. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.
Hughes RA
Expert Rev Neurother; 2009 Jun; 9(6):789-95. PubMed ID: 19496683
[TBL] [Abstract][Full Text] [Related]
38. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
Nobile-Orazio E; Bersano A
Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
[No Abstract] [Full Text] [Related]
39. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
Joint Task Force of the EFNS and the PNS
J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of chronic inflammatory demyelinating polyradiculoneuropathy(CIDP)--a review].
Mezaki T; Kaji R
No To Shinkei; 2000 Dec; 52(12):1063-9. PubMed ID: 11193538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]